SCHEMBL2434347

SCHEMBL2434347

COC(=O)[C@H]1CC[C@H](OC(OCC(=O)Cc2cc(Cl)c(NC(=O)c3nn(C)c4ccccc34)cc2F)N2CCCC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 11/20 0.44
ITGA4 P13612 11/20 0.44
KDM1A O60341 1/20 0.38
KDM4E B2RXH2 1/20 0.36
HTR3A P46098 2/20 0.35
HTR3E A5X5Y0 1/20 0.35
SLC22A2 O15244 1/20 0.35
HTR3B O95264 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
KCNH2 Q12809 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
SLC47A1 Q96FL8 1/20 0.35
WDR5 P61964 2/20 0.35
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7270022 1.00 ITGB1 (0.44) ITGB1ITGA4KDM1AKDM4EHTR3A
SCHEMBL2430016 0.94 ITGB1 (0.51) ITGB1ITGA4KDM1AKDM4EHTR3A
SCHEMBL2430292 0.92 ITGB1 (0.44) ITGB1ITGA4KDM1AKDM4EHTR3A
SCHEMBL2430235 0.88 ITGB1 (0.58) ITGB1ITGA4KDM1AALDH1A1
SCHEMBL6764792 0.88 ITGB1 (0.58) ITGB1ITGA4KDM1AALDH1A1
SCHEMBL2429372 0.86 ITGB1 (0.50) ITGB1ITGA4KDM1AKDM4EHTR3A
SCHEMBL2430290 0.85 ITGB1 (0.43) ITGB1ITGA4KDM1AKDM4EHTR3A
SCHEMBL2434349 0.83 ITGB1 (0.55) ITGB1ITGA4KDM1AWDR5
SCHEMBL2432749 0.82 ITGB1 (0.66) ITGB1ITGA4KDM1A
SCHEMBL5373224 0.82 ITGB1 (0.49) ITGB1ITGA4KDM1AKDM4EWDR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1346982-B1 VLA-4 INHIBITORS DAIICHI SEIYAKU CO (JP) 2011-09-14 EP disclosed
US-7157487-B2 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 US disclosed
US-20040110945-A1 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-06-10 US disclosed
EP-1346982-A1 VLA-4 INHIBITORS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-09-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110945-A1 Vla-4 inhibitors VCAM1, ITGA1, ITGB4 ITGB1 5/4885ITGA4 4/4885KDM1A 816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.